Luteinizing hormone-releasing hormone (LHRH) agonists (also called LHRH analogs or GnRH agonists) are drugs that lower the amount of.
A fact sheet that describes hormone therapy and its role in treating prostate cancer. Includes information about the types of hormone therapy.
A substance that keeps the testicles and ovaries from making sex hormones by blocking other hormones that are needed to make them. In men, LHRH agonists .
These medications, known as anti-androgens, usually are given in conjunction with LHRH agonists. That's because LHRH agonists can cause.
LHRH agonists (luteinizing hormone-releasing hormone agonists) are the most common type of injection or implant. There are several different LHRH agonists.
The most recent guidelines on prostate cancer screening from the American Urological Association (), the National Comprehensive Cancer Network ( ).
Crawford and Hou review the data on luteinizing hormone-releasing hormone (LHRH) antagonists in prostate cancer. They describe the.
The luteinizing hormone-releasing hormone agonists are a type of ovarian suppression offered to pre- and perimenopausal women with breast.